Immunoregulator
CA 2407046 C · Owner: Erasmus Universiteit Rotterdam · Inventors: Benner, Robbert; Khan, Nisar Ahmed
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the field of immunology more specifically to the , field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease or inflammatory disease. The invention provides among others an immunoregulator (NMPF), use of an NMPF in preparing a pharmaceutical composition for treating an immune-mediated disorder a pharmaceutical composition and a method for treating an immune-mediated disorder.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 29, 2001 and granted February 15, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 29, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 29, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.